Low Rate of Complications With Assisted Reproductive Technology

Share this content:
Low Rate of Complications With Assisted Reproductive Technology
Low Rate of Complications With Assisted Reproductive Technology

(HealthDay News) -- Assisted reproductive technology procedures performed in the United States from 2000 to 2011 are associated with low risk of complications, according to a research letter published in the Jan. 6 issue of the Journal of the American Medical Association.

Jennifer Kawwass, M.D., of the Emory University School of Medicine in Atlanta, and colleagues conducted a review spanning the years 2000 to 2011. The review was based on a surveillance system established by the U.S. Centers for Disease Control and Prevention. The researchers said that reported complications had to be directly related to ART and take place within 12 weeks of the procedure. Possible problems included infection, bleeding, complications related to anesthesia, hospitalization, and death.

The researchers found that the risk of complications was low for both autologous and donor-assisted procedures. Among 1,135,206 autologous ART cycles, the most commonly reported patient complications were ovarian hyperstimulation syndrome (OHSS) and hospitalization. "Increased awareness of the most common complication, OHSS, may prompt additional study to characterize predictors of this and other adverse events to inform the development of effective approaches necessary to decrease complication occurrence," the authors write.

The researchers noted that rates of all other complications remained below 10 per 10,000 cycles. The study authors said they identified 58 deaths associated with ART during the study period. Of these, 18 deaths were related to ovarian stimulation and 40 others occurred before delivery. Overall, the death rates for women who had an ART-conceived live birth ranged from 14.2 per 100,000 in 2004 to 1.6 per 100,000 in 2008.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths